Aoife Brennan Insider Trading $SYBX SYNLOGIC, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Aoife Brennan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Aoife Brennan. Aoife Brennan is Director in FIBROGEN INC ($FGEN) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Chief Medical Officer in SYNLOGIC, INC. ($MIRN) and Interim President and CEO in SYNLOGIC, INC. ($SYBX) and President and CEO in SYNLOGIC, INC. ($SYBX) and See Remarks in SYNLOGIC, INC. ($SYBX).
Aoife Brennan in SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Aoife Brennan: See Remarks, Interim President and CEO, Chief Medical Officer
Holdings: 177,317 shares
Current Value: $390,097
Latest Transaction: Mar 12 2021
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Aoife Brennan in SYNLOGIC, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FGEN, RARX, SYBX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 3.50 | 285,000 | 997,500 | 285,000 | |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Mar 12 2021 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 71,250 | 0 | 177,317 | 106.1 K to 177.3 K (+67.17 %) |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 1.70 | 185,300 | 315,010 | 185,300 | |
| Mar 12 2020 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 46,300 | 0 | 106,067 | 59.8 K to 106.1 K (+77.47 %) |
| Sep 25 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Grant | A | 0.00 | 8,000 | 0 | 59,767 | 51.8 K to 59.8 K (+15.45 %) |
| Mar 06 2019 | SYBX | SYNLOGIC, INC. | Brennan Aoife | See Remarks | Option Exercise | A | 8.59 | 185,000 | 1,589,150 | 185,000 | |
| Nov 01 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | President and CEO | Option Exercise | A | 7.91 | 150,000 | 1,186,500 | 150,000 | |
| Jun 06 2018 | SYBX | SYNLOGIC, INC. | Brennan Aoife | Interim President a ... | Option Exercise | A | 9.55 | 54,000 | 515,700 | 54,000 | |
| Mar 15 2018 | MIRN | SYNLOGIC, INC. | Brennan Aoife | Chief Medical Offic ... | Option Exercise | A | 9.95 | 56,000 | 557,200 | 56,000 |
Page: 1